Long-Acting Antiretroviral Therapies vs. Conventional Oral Regimens in HIV: A Systematic Review

Simple item page
dc.contributor.authorCalderon Chacon, Janinne
dc.contributor.authorGaray Borcosque, Andres M.
dc.contributor.authorLijeron Viana de Araujo, Luccas
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T13:39:15Z
dc.date.available2026-03-22T13:39:15Z
dc.date.issued2025
dc.description.abstractBackground: Long-acting antiretroviral therapies (ARV-LA) have emerged as an alternative to daily oral regimens for the management of HIV. This systematic review evaluates the efficacy, safety, and patient satisfaction of ARV-LA, particularly focusing on cabotegravir (CAB-LA) and rilpivirine (RPV-LA), in comparison to standard oral antiretroviral therapies (ART).
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/41931
dc.language.isoen
dc.sourceUniversidad Católica Boliviana
dc.subjectHIV
dc.subjectLong-Acting Antiretroviral Therapy
dc.subjectCabotegravir
dc.subjectRilpivirine
dc.subjectViral Suppression
dc.subjectSafety
dc.titleLong-Acting Antiretroviral Therapies vs. Conventional Oral Regimens in HIV: A Systematic Review
dc.typeArticle

Files

Collections

Artículo Científico Publicado